Cargando…

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study

Detalles Bibliográficos
Autores principales: Vadhan-Raj, Saroj, Ford, David C, Dahl, Naomi V, Bernard, Kristine, Li, Zhu, Allen, Lee F, Strauss, William E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725221/
https://www.ncbi.nlm.nih.gov/pubmed/26572233
http://dx.doi.org/10.1002/ajh.24240
_version_ 1782411613205168128
author Vadhan-Raj, Saroj
Ford, David C
Dahl, Naomi V
Bernard, Kristine
Li, Zhu
Allen, Lee F
Strauss, William E
author_facet Vadhan-Raj, Saroj
Ford, David C
Dahl, Naomi V
Bernard, Kristine
Li, Zhu
Allen, Lee F
Strauss, William E
author_sort Vadhan-Raj, Saroj
collection PubMed
description
format Online
Article
Text
id pubmed-4725221
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-47252212016-02-03 Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study Vadhan-Raj, Saroj Ford, David C Dahl, Naomi V Bernard, Kristine Li, Zhu Allen, Lee F Strauss, William E Am J Hematol E-Only Articles John Wiley & Sons, Ltd 2016-02 2016-01-22 /pmc/articles/PMC4725221/ /pubmed/26572233 http://dx.doi.org/10.1002/ajh.24240 Text en © 2015 The Authors. American Journal of Hematology Published by Wiley Periodicals, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle E-Only Articles
Vadhan-Raj, Saroj
Ford, David C
Dahl, Naomi V
Bernard, Kristine
Li, Zhu
Allen, Lee F
Strauss, William E
Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study
title Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study
title_full Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study
title_fullStr Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study
title_full_unstemmed Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study
title_short Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study
title_sort safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: results of a phase iii, open-label, 6-month extension study
topic E-Only Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725221/
https://www.ncbi.nlm.nih.gov/pubmed/26572233
http://dx.doi.org/10.1002/ajh.24240
work_keys_str_mv AT vadhanrajsaroj safetyandefficacyofferumoxytolfortheepisodictreatmentofirondeficiencyanemiainpatientswithahistoryofunsatisfactoryoralirontherapyresultsofaphaseiiiopenlabel6monthextensionstudy
AT forddavidc safetyandefficacyofferumoxytolfortheepisodictreatmentofirondeficiencyanemiainpatientswithahistoryofunsatisfactoryoralirontherapyresultsofaphaseiiiopenlabel6monthextensionstudy
AT dahlnaomiv safetyandefficacyofferumoxytolfortheepisodictreatmentofirondeficiencyanemiainpatientswithahistoryofunsatisfactoryoralirontherapyresultsofaphaseiiiopenlabel6monthextensionstudy
AT bernardkristine safetyandefficacyofferumoxytolfortheepisodictreatmentofirondeficiencyanemiainpatientswithahistoryofunsatisfactoryoralirontherapyresultsofaphaseiiiopenlabel6monthextensionstudy
AT lizhu safetyandefficacyofferumoxytolfortheepisodictreatmentofirondeficiencyanemiainpatientswithahistoryofunsatisfactoryoralirontherapyresultsofaphaseiiiopenlabel6monthextensionstudy
AT allenleef safetyandefficacyofferumoxytolfortheepisodictreatmentofirondeficiencyanemiainpatientswithahistoryofunsatisfactoryoralirontherapyresultsofaphaseiiiopenlabel6monthextensionstudy
AT strausswilliame safetyandefficacyofferumoxytolfortheepisodictreatmentofirondeficiencyanemiainpatientswithahistoryofunsatisfactoryoralirontherapyresultsofaphaseiiiopenlabel6monthextensionstudy